Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
causaLens is a London-based technology company that pioneered Causal AI, a branch of artificial intelligence that goes beyond pattern recognition to understand cause-and-effect relationships. The company's flagship platform, decisionOS, enables organizations in the life sciences and healthcare sectors to discover new biomarkers, optimize clinical trial designs, and accelerate drug discovery processes. By moving from correlation-based models to causal ones, causaLens helps researchers identify the underlying drivers of disease and predict how patients will respond to specific treatments. Their technology is utilized by leading pharmaceutical companies and healthcare institutions to enhance decision-making and improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on causaLens.